Tag

Drug Recall

All articles tagged with #drug recall

health18 days ago•12 min saved

FDA classifies Inventia’s chlorthalidone recall as Class II after dissolution failures

The FDA has classified a nationwide recall of over 25,000 bottles of chlorthalidone 25 mg tablets as Class II, citing failures in dissolution specifications that may impair drug absorption. Manufactured by India-based Inventia Healthcare Limited, the affected batches were distributed across the United States. Patients are advised to consult their healthcare providers before discontinuing the medication, as stopping treatment may pose greater risks than continuing use of the recalled product.

via USA Today|

#blood-pressure #chlorthalidone #drug-recall

health19 days ago•58 min saved

FDA Upgrades Chlorthalidone Recall to Class II After Dissolution Failures

The FDA has escalated a nationwide recall of 13,567 bottles of chlorthalidone 25mg tablets to Class II status due to failures in dissolution specifications. Manufactured by Inventia Healthcare Limited, the affected medication was distributed across the US and is identified by NDC number 64980-599-01. This is the second recall for this specific drug in three months, following a similar issue with Rising Pharma Holdings in June. Patients are advised to stop using the affected product and consult their healthcare provider for an alternative.

via Yahoo|

#blood-pressure #chlorthalidone #drug-recall

health19 days ago•37 min saved

FDA Classifies Second Chlorthalidone Recall as Class II Due to Dissolution Failures

The FDA has classified a second nationwide recall of chlorthalidone tablets as Class II, affecting over 13,000 bottles. Manufactured by Inventia Healthcare, the medication failed dissolution tests, potentially reducing its effectiveness for treating high blood pressure. Patients are advised to contact their healthcare providers before stopping the medication.

via Yahoo News Singapore|

#chlorthalidone #drug-recall #fda

health23 days ago•77 min saved

FDA Issues Class II Recall for 13,567 Bottles of Chlorthalidone Due to Dissolution Failures

The FDA has announced a Class II recall of 13,567 bottles of chlorthalidone 25mg tablets nationwide after the medication failed dissolution tests. This is the second recall for this specific drug and manufacturer in three months, affecting patients who rely on the medication for hypertension and fluid retention.

via AOL.com|

#chlorthalidone #drug-recall #fda

health23 days ago•79 min saved

FDA classifies Vitruvia thyroid recall as highest risk due to superpotency

The FDA has upgraded the recall of Vitruvia Therapeutics 30 mg thyroid tablets to Class I, its highest risk level, because the pills may be superpotent. Approximately 1,900 units distributed nationwide between January and September 2025 are affected. Patients should not stop taking the medication without consulting a doctor, as overactive thyroid symptoms can occur.

via AOL.com|

#class-i #drug-recall #fda

health3 months ago•2 min saved

FDA recalls millions of Prednisolone eye drops over potential contaminant

The FDA is recalling more than 2.5 million bottles of Prednisolone Acetate Ophthalmic Suspension eye drops from Lupin Pharmaceuticals due to a possible foreign substance; the Class II recall indicates temporary or reversible health effects, and consumers should immediately stop using the recalled bottles and check the FDA enforcement report for affected lots.

via USA Today|

#drug-recall #eye-drops #fda-enforcement

health10 months ago•6 min saved

Atorvastatin Recall Highlights FDA Inspection Challenges Abroad

The recall of thousands of atorvastatin bottles due to manufacturing defects highlights ongoing issues with overseas drug production and FDA oversight, risking reduced drug efficacy and increased cardiovascular risks for millions of patients.

via Yahoo|

#atorvastatin #drug-recall #fda

health1 year ago•2 min saved

Nationwide Clonazepam Recall Expanded Due to Labeling Errors

Endo, Inc. has issued a nationwide recall of Clonazepam Orally Disintegrating Tablets due to a labeling error that could lead to potentially fatal overdoses. The error, made by a third-party packager, involves incorrect strength and National Drug Code on some cartons, though the blister strips and tablets are correctly labeled. The mislabeled drugs pose a risk of life-threatening respiratory depression, especially for vulnerable patients. Consumers are advised to stop using the affected tablets and consult a doctor if they have taken the wrong dose.

via TODAY|

#clonazepam #drug-recall #endo-inc